Of note, the effectiveness of the triple combination in that study was mainly ascribed to the use of interferon beta, which has potential to prevent SARS-CoV-2 from shutting down the host innate immunity in the first few days from infection (Richardson et al., 2020). This evidence concerns the gene IFNB1 and infection.